S.A. Mason’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
S.A. Mason's DGX Position: Q3 2026 in Review
S.A. Mason held its Quest Diagnostics (DGX) position steady in Q3 2026 at 1,900 shares worth $443K. The position accounts for 0.13% of the portfolio, ranked #146.
S.A. Mason first reported a position in DGX in Q4 2019 and has held it in 28 quarters since. 266 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- S.A. Mason held 1,900 shares of Quest Diagnostics worth $443K as of Q3 2026.
- S.A. Mason left its Quest Diagnostics share count unchanged in Q3 2026.
- Quest Diagnostics made up 0.13% of S.A. Mason's portfolio in Q3 2026, its #146 holding.
- S.A. Mason first reported a position in Quest Diagnostics in Q4 2019 and has held it in 28 quarters since.
- 266 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on S.A. Mason's 13F filing for Q3 2026, filed 13 Oct 2026.